摘要:
The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.
摘要:
The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.
摘要:
The invention provides a compound of formula (Ia), and pharmaceutically acceptable salts thereof. The invention also provides use of the compounds or salts as modulators of Kv3.1 and/or Kv3.2, and in the treatment of diseases or disorders where a modulator of Kv3.1 and/or Kv3.2 is required, such as depression and mood disorders, hearing disorders, schizophrenia, substance abuse disorders, sleep disorders or epilepsy.
摘要:
The invention provides a compound of formula (Ia), and pharmaceutically acceptable salts thereof. The invention also provides use of the compounds or salts as modulators of Kv3.1 and/or Kv3.2, and in the treatment of diseases or disorders where a modulator of Kv3.1 and/or Kv3.2 is required, such as depression and mood disorders, hearing disorders, schizophrenia, substance abuse disorders, sleep disorders or epilepsy.
摘要:
Compounds of formula (I) or a pharmaceutically acceptable salt thereof. wherein R is hydrogen or C1-4 alkyl; R1 is hydrogen, C1-4 alkyl, C(O)OH, C(O)NH2 or (C1-4 alkylene)R10; R2 and R3 are independently hydrogen, C1-4 alkyl or R2 together with R3 and together with the carbon atom to which they are attached form a C3-8 cycloalkyl group; R4 is C1-4 alkyl, C1-4 alkoxy or halogen; R5 and R7 are independently hydrogen, hydroxy, halogen, C(O)NH2, C(O)OH or (C1-4 alkylene)R10; R6 and R8 are independently hydrogen or halogen; R9 is hydrogen, (C1-4 alkylene)R10, C(O)NH2, C(O)OH or R9 together with R form a 6 membered heterocyclic ring optionally containing a further heteroatom selected from oxygen, sulphur or nitrogen; R10 is hydrogen, halogen, hydroxy, C(O)NH2, C(O)NH(C1-4 alkyl), C(O)N(C1-4 alkyl)2 or C(O)OH; n is 0, 1 or 2. processes for their preparation, to compositions containing them and to their use in the treatment of diseases and conditions for which antagonism of NK1 is beneficial.
摘要翻译:式(I)化合物或其药学上可接受的盐。 其中R是氢或C 1-4烷基; R 1是氢,C 1-4烷基,C(O)OH,C(O)NH 2或(C 1-4亚烷基)R 10; R2和R3独立地为氢,C1-4烷基或R2与R3一起并与它们所连接的碳原子一起形成C 3-8环烷基; R4是C1-4烷基,C1-4烷氧基或卤素; R 5和R 7独立地是氢,羟基,卤素,C(O)NH 2,C(O)OH或(C 1-4亚烷基)R 10; R6和R8独立地是氢或卤素; R9是氢,(C1-4亚烷基)R10,C(O)NH2,C(O)OH或R9与R一起形成任选地含有另外选自氧,硫或氮的杂原子的6元杂环; R 10是氢,卤素,羟基,C(O)NH 2,C(O)NH(C 1-4烷基),C(O)N(C 1-4烷基)2或C(O) n为0,1或2.其制备方法,含有它们的组合物及其在治疗NK1拮抗作用有益的疾病和病症中的用途。
摘要:
The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R is C1-4 alkyl useful in the treatment of diseases and conditions for which antagonism of NK1 receptor is beneficial.
摘要:
Compounds of formula (I) or a pharmaceutically acceptable salt thereof wherein R is hydrogen or C1-4 alkyl; R1 is hydrogen, C1-4 alkyl, C(O)OH, C(O)NH2 or (C1-4 alkylene)R10; R2 and R3 are independently hydrogen, C1-4 alkyl or R2 together with R3 and together with the carbon atom to which they are attached form a C3-8 cycloalkyl group; R4 is C1-4 alkyl, C1-4 alkoxy or halogen; R5 and R7 are independently hydrogen, hydroxy, halogen, C(O)NH2, C(O)OH or (C1-4 alkylene) R10; R6 and R8 are independently hydrogen or halogen; R9 is hydrogen, (C1-4 alkylene)R10, C(O)NH2, C(O)OH or R9 together with R form a 6 membered heterocyclic ring optionally containing a further heteroatom selected from oxygen, sulphur or nitrogen; R10 is hydrogen, halogen, hydroxy, C(O)NH2, C(O)NH(C1-4 alkyl), C(O)N(C1-4 alkyl)2 or C(O)OH; n is 0, 1 or 2. processes for their preparation, to compositions containing them and to their use in the treatment of diseases and conditions for which antagonism of NK1 is beneficial.
摘要翻译:式(I)化合物或其药学上可接受的盐,其中R是氢或C 1-4烷基; R 1是氢,C 1-4烷基,C(O)OH,C(O)NH 2或(C 1-4亚烷基)R 10; R2和R3独立地为氢,C1-4烷基或R2与R3一起并与它们所连接的碳原子一起形成C 3-8环烷基; R4是C1-4烷基,C1-4烷氧基或卤素; R 5和R 7独立地是氢,羟基,卤素,C(O)NH 2,C(O)OH或(C 1-4亚烷基)R 10; R6和R8独立地是氢或卤素; R9是氢,(C1-4亚烷基)R10,C(O)NH2,C(O)OH或R9与R一起形成任选地含有另外选自氧,硫或氮的杂原子的6元杂环; R 10是氢,卤素,羟基,C(O)NH 2,C(O)NH(C 1-4烷基),C(O)N(C 1-4烷基)2或C(O) n为0,1或2.其制备方法,含有它们的组合物及其在治疗NK1拮抗作用有益的疾病和病症中的用途。
摘要:
The invention relates to quaternary α-aminocarboxyamide derivatives of formula (I) and their pharmaceutically salts or solvates wherein R1 is H or CH3; and R2 is H or CH3, for treating diseases and conditions mediated by modulation of voltage-gated sodium channels.
摘要:
The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R is C1-4 alkyl useful in the treatment of diseases and conditions for which antagonism of NK1 receptor is beneficial.